47045-TJK-C-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Strengthening Supportive Environment and Scaling up Prevention, Treatment and Care to reduce the burden of HIV and TB in the Republic of Tajikistan - Tajikistan (01-Jan-2021-31-Dec-2023)</narrative> Tajikistan, TB/HIV, United Nations Development Programme Goal: To reduce the burden of HIV and TB in Tajikistan. Objectives: To ensure effective HIV response measures among most at risk populations, - including prevention, early HIV diagnostics and immediate treatment initiation, - to reach 90-90-90 HIV care targets; To scale up access for early and quality TB, DR-TB and LTBI diagnosis, treatment and care; To ensure integrated care for people affected both by TB and HIV disease; To strengthen national public heath response to ensure universal, patient-centered, efficient, human rights and gender sensitive approach to HIV, TB and integrated TB/HIV services. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Olga Avdeeva Fund Portfolio Manager +41 58 791 1700 olga.avdeeva@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Tajikistan HIV Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing HIV -> Differentiated HIV Testing Services -> Facility-based testing HIV -> Prevention -> Behavior change interventions HIV -> Prevention -> Condom and lubricant programming HIV -> Prevention -> Needle and syringe programs HIV -> Prevention -> Opioid substitution therapy and other medically assisted drug dependence treatment HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB) HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health management information systems and M&E -> Routine reporting RSSH -> RSSH: Health management information systems and M&E -> Surveys RSSH -> RSSH: Health products management systems -> Procurement capacity RSSH -> RSSH: Human resources for health, including community health workers -> Community health workers: Education and production RSSH -> RSSH: Human resources for health, including community health workers -> Education and production of new health workers (excluding community health workers) Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Treatment (MDR-TB) 3259597.37 13805241.49 13494169.75 3080399.19 16843513.01 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8745562.81 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -8097950.20 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 13766048.20 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1054452.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4282979.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2257140.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 197114.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -50000.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 100000.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund disbursement to TJK-C-UNDPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 10711572.38 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -5974363.20 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3201090.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 237011.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -50000.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 680127.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 108185.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5068029.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 95643.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5596313.34 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -1321487.38 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1310393.34 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 100000.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2619067.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 468608.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 500000.00 Global Fund disbursement to TJK-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 100000.00 Global Fund disbursement to TJK-C-UNDPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -39690.23 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 39690.23 Funds returned to the Global Fund from TJK-C-UNDPP01 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -519217.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 519217.00 Funds returned to the Global Fund from TJK-C-UNDPP01 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -698245.00 Global Fund commitment to TJK-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3259597.39 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP01, Jan 2021 to Dec 2021. United Nations Development Programme 12644140.86 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP01, Jan 2022 to Dec 2022. United Nations Development Programme 11898381.97 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP01, Jan 2023 to Dec 2023. United Nations Development Programme 2742311.92 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP01, Jan 2024 to Jun 2024. United Nations Development Programme 99372.43 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP01, Jul 2024 to Mar 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 1 - TB/HIV - Tajikistan - English</narrative> Funding Request of funding request FR915-TJK-C. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 4634; Denominator: 13400. Numerator: 5678; Denominator: 13400. Numerator: 4398; Denominator: 13400. Numerator: 6075; Denominator: 13400. Numerator: 5199; Denominator: 13400. Numerator: 6501; Denominator: 13400. Numerator: 5760; Denominator: 13400. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 9440; Denominator: 22200. Numerator: 12540; Denominator: 22200. Numerator: 11159; Denominator: 22200. Numerator: 12915; Denominator: 22200. Numerator: 12233; Denominator: 22200. Numerator: 13746; Denominator: 22200. Numerator: 11277; Denominator: 22200. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 7413; Denominator: 17600. Numerator: 8686; Denominator: 17600. Numerator: 7108; Denominator: 17600. Numerator: 9554; Denominator: 17600. Numerator: 8603; Denominator: 17600. Numerator: 10510; Denominator: 17600. Numerator: 9529; Denominator: 17600. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. <narrative>Number of people in prisons and other closed settings reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Number of people in prisons and other closed settings reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Module: Prevention. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Geographic coverage: National, 100% of national program target. Numerator: 62; Denominator: 109. Numerator: 148; Denominator: 211. Numerator: 76; Denominator: 122. Numerator: 188; Denominator: 250. Numerator: 98; Denominator: 174. Numerator: 200; Denominator: 250. Numerator: 69; Denominator: 116. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 6682; Denominator: 13400. Numerator: 7097; Denominator: 13400. Numerator: 7700; Denominator: 13400. Numerator: 7594; Denominator: 13400. Numerator: 7036; Denominator: 13400. Numerator: 8126; Denominator: 13400. Numerator: 7105; Denominator: 13400. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 13653; Denominator: 22200. Numerator: 15674; Denominator: 22200. Numerator: 13258; Denominator: 22200. Numerator: 16144; Denominator: 22200. Numerator: 14644; Denominator: 22200. Numerator: 17183; Denominator: 22200. Numerator: 13052; Denominator: 22200. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 10601; Denominator: 17600. Numerator: 10857; Denominator: 17600. Numerator: 10075; Denominator: 17600. Numerator: 11943; Denominator: 17600. Numerator: 12087; Denominator: 17600. Numerator: 13137; Denominator: 17600. Numerator: 11813; Denominator: 17600. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB/HIV. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: Treatment, care and support. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Numerator: 45; Denominator: 48. Numerator: 115; Denominator: 122. Numerator: 115; Denominator: 115. Numerator: 133; Denominator: 133. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 7086; Denominator: 14000. Numerator: 9305; Denominator: 14000. Numerator: 8740; Denominator: 14000. Numerator: 10305; Denominator: 14000. Numerator: 9535; Denominator: 14000. Numerator: 11305; Denominator: 14000. Numerator: 10472; Denominator: 14000. 47045-TJK-C-UNDP-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Ending HIV and tuberculosis (“TB”) epidemics through evidence-based interventions and innovative approaches with a focus on key and vulnerable populations - Tajikistan (01-Jan-2024-31-Dec-2026)</narrative> Tajikistan, TB/HIV, United Nations Development Programme Goals: To support Tajikistan public health system by ensuring HIV prevention, timely detection, access to ART, addressing related human rights barriers, as well as providing quality HIV care and support with the focus on key and vulnerable populations; To decrease the burden of tuberculosis and its impact over the general social and economic development in the country, by ensuring universal access to timely and quality diagnosis and treatment of all forms of TB, including latent TB, which will decrease illness and deaths and prevent further development of drug resistance. Objectives: To ensure effective HIV response measures among most at risk populations, - including prevention, early HIV diagnostics and immediate treatment initiation, - to reach 95-95-95 HIV care targets; To reach the pre-pandemic level of access to early and quality DR-TB diagnostics and treatment and scale up integrated people-centered model of TB care; To dramatically scale up efforts on TB/DR-TB prevention, including universal access to TB preventive treatment; To ensure integrated care for people affected both by TB and HIV disease; To strengthen national public heath response to ensure universal, people-centered, efficient, human rights and gender-responsive approach to HIV, TB and integrated TB/HIV services. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Olga Avdeeva Fund Portfolio Manager +41 58 791 1700 olga.avdeeva@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Tajikistan HIV Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for people in prisons and other closed settings -> Harm reduction interventions for drug use for prisoners HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Condom and lubricant programming for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation RSSH -> RSSH: Health sector planning and governance for integrated people-centered services -> Integration/coordination across disease programs and at the service delivery level RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/HIV -> TB/HIV - Key populations Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis 5518945.54 8442683.53 9395214.06 10977476.00 Global Fund commitment to TJK-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 6489759.00 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 500000.00 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3468500.00 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -519217.00 Global Fund commitment to TJK-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3700263.00 Global Fund commitment to TJK-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3700263.00 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 519217.00 Global Fund commitment to TJK-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 519217.00 Global Fund disbursement to TJK-C-UNDPP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2348803.53 Global Fund commitment to TJK-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2348803.53 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5007156.83 Global Fund commitment to TJK-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3200000.00 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1059974.83 Global Fund disbursement to TJK-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5518945.54 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP02, Jan 2024 to Dec 2024. United Nations Development Programme 6909925.30 Expenditure reported by United Nations Development Programme for TJK-C-UNDPP02, Jan 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - TB/HIV - Tajikistan - English</narrative> Funding Request of funding request FR1411-TJK-C. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 10400. Numerator: 600; Denominator: 15450; Percentage: 3.88%. Numerator: 10400; Denominator: 15450; Percentage: 67.31%. Numerator: 9500. Numerator: 9600. Numerator: 242. Numerator: 9358. Numerator: 9500. Numerator: 11170. Numerator: 9500. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 5199; Denominator: 13400. Numerator: 4443; Denominator: 12000. Numerator: 4151; Denominator: 12000. Numerator: 7773; Denominator: 12000. Numerator: 3238; Denominator: 12000. Numerator: 9180; Denominator: 12000. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 8630; Denominator: 17600. Numerator: 9404; Denominator: 18500. Numerator: 7727; Denominator: 18500. Numerator: 12389; Denominator: 18500. Numerator: 8046; Denominator: 18500. Numerator: 14256; Denominator: 18500. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 551; Denominator: 606. Numerator: 327; Denominator: 373. Numerator: 263; Denominator: 268. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Numerator: 482; Denominator: 487. Numerator: 343; Denominator: 373. Numerator: 265; Denominator: 268. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention package for men who have sex with men (MSM) and their sexual partners. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 7036; Denominator: 13400. Numerator: 5703; Denominator: 12000. Numerator: 4197; Denominator: 12000. Numerator: 9145; Denominator: 12000. Numerator: 5145; Denominator: 12000. Numerator: 10200; Denominator: 12000. <narrative>Number of people in prisons and other closed settings reached with HIV prevention programs</narrative> Module: Prevention package for people in prisons and other closed settings. <narrative>Number of people in prisons and other closed settings reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Module: Prevention package for people who use drugs (PUD) and their sexual partners. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 14644; Denominator: 22200. Numerator: 15000; Denominator: 18200. Numerator: 12402; Denominator: 18200. Numerator: 16348; Denominator: 18200. Numerator: 11837; Denominator: 18200. Numerator: 17200; Denominator: 18200. <narrative>Percentage of people who inject drugs receiving opioid substitution therapy</narrative> Module: Prevention package for people who use drugs (PUD) and their sexual partners. <narrative>Percentage of people who inject drugs receiving opioid substitution therapy</narrative> Geographic coverage: National, 100% of national program target. Numerator: 662; Denominator: 22200. Numerator: 1175; Denominator: 18200. Numerator: 598; Denominator: 18200. Numerator: 1625; Denominator: 18200. Numerator: 613; Denominator: 18200. Numerator: 2000; Denominator: 18200. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention package for sex workers, their clients and other sexual partners. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 12087; Denominator: 17600. Numerator: 11467; Denominator: 18500. Numerator: 8070; Denominator: 18500. Numerator: 14575; Denominator: 18500. Numerator: 9505; Denominator: 18500. Numerator: 15840; Denominator: 18500. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Numerator: 3876; Denominator: 4441. Numerator: 3485; Denominator: 4095. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Numerator: 115; Denominator: 120. Numerator: 92; Denominator: 98. Numerator: 69; Denominator: 71. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 9535; Denominator: 14000. Numerator: 11400; Denominator: 15000. Numerator: 11268; Denominator: 15000. Numerator: 12678; Denominator: 15000. Numerator: 12097; Denominator: 13878. Numerator: 14250; Denominator: 15000. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Module: Treatment, care and support. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Geographic coverage: National, 100% of national program target. Numerator: 245; Denominator: 251. Numerator: 275; Denominator: 261.